We evaluated the sensitivity of tumor cells (IC50 values) for a panel of chemotherapeutic drugs using the WST-test as well as MDR1 mRNA and P-gp levels as one of the possible mechanisms of drug resistance for leukemia patients prior to the start of cytotoxic therapy. Here, ABCB1 is linked to neoplasm.